Nykode Therapeutics AS (OSL:NYKD)
Norway · Delayed Price · Currency is NOK 4.805
+0.205 (4.46%)
Aug 27, 2026, 9:25 AM CET
Nykode Therapeutics AS Market Cap
Nykode Therapeutics AS has a market cap or net worth of 1.5 billion as of August 26, 2026. Its market cap has increased by 163.31% in one year.
Market Cap
1.50B
Enterprise Value
1.08B
Revenue
4.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.81
ChartMarket Cap Chart
Since January 28, 2020, Nykode Therapeutics AS's market cap has decreased from 5.52B to 1.50B, a decrease of -72.81%. That is a compound annual growth rate of -17.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 1.52B | 92.37% |
| Dec 30, 2025 | 787.63M | -20.81% |
| Dec 30, 2024 | 994.66M | -85.77% |
| Dec 29, 2023 | 6.99B | -15.67% |
| Dec 30, 2022 | 8.29B | -64.54% |
| Dec 30, 2021 | 23.37B | 9.44% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 2.84B |
| Thor Medical ASA | 2.43B |
| ArcticZymes Technologies ASA | 1.04B |
| Zelluna ASA | 638.28M |
| Lytix Biopharma ASA | 598.28M |
| Oncoinvent ASA | 380.67M |
| SoftOx Solutions AS | 249.77M |
| Arctic Bioscience AS | 77.09M |